| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/18/2002 | WO2002030860A2 Ketone compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030461A2 Methods for treating disorders of the female reproductive system |
| 04/18/2002 | WO2002030404A2 Combination therapy for premenstrual symptoms |
| 04/18/2002 | WO2002030393A2 Polymeric delivery formulations of leuprolide with improved efficacy |
| 04/18/2002 | WO2002030355A2 Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase |
| 04/18/2002 | WO2002017914A3 Fused pyrrolocarbazoles against inflammation |
| 04/18/2002 | WO2002011742A3 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 04/18/2002 | WO2002003995A3 Treatment of male sexual dysfunction |
| 04/18/2002 | WO2001087265A3 Pharmaceutical form of administration for peptides, methods for its production and use |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001068570A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068569A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001066595A3 Human fgf-23 gene and gene expression products |
| 04/18/2002 | WO2001064681A3 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 04/18/2002 | WO2001060318A3 Protection of the female reproductive system from natural and artificial insults |
| 04/18/2002 | WO2001026644A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/18/2002 | WO2000068385A9 Novel nucleic acids and proteins with growth hormone activity |
| 04/18/2002 | WO2000066106A9 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 04/18/2002 | US20020045665 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 04/18/2002 | US20020045652 Prophylactic or therapeutic drug for renal diseases |
| 04/18/2002 | US20020045648 Therapeutic compositions comprising excess enantiomer |
| 04/18/2002 | US20020045635 Novel mGluR antagonists and a method for their synthesis |
| 04/18/2002 | US20020045614 1-(4-(((4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino) methyl)-4-phenyl-piperidin-1-yl)-1-cyclopropyl-methanone; treating disease states ameliorated by blockade of alpha-1 adrenoceptors; sleep/psychological disorders |
| 04/18/2002 | DE10050995A1 New benzylic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease |
| 04/18/2002 | DE10050994A1 New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease |
| 04/18/2002 | DE10049736A1 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 17alpha-Fluoroalkyl steroids, processes for their preparation and pharmaceutical compositions containing them |
| 04/18/2002 | CA2462081A1 Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase |
| 04/18/2002 | CA2425678A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2425674A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2425121A1 Ether compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | CA2424802A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 04/18/2002 | CA2424107A1 Sulfonylguanidines |
| 04/18/2002 | CA2394084A1 Inhibitors of protein kinases |
| 04/17/2002 | EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 04/17/2002 | EP1197217A1 Use of sodium nitroprussiate in obstetrics and gynaecology |
| 04/17/2002 | EP1197208A1 Sustained release compositions, process for producing the same and use thereof |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196569A2 Electron transfer proteins |
| 04/17/2002 | EP1196568A1 Human lim domain proteins |
| 04/17/2002 | EP1196442A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196428A1 11$g(b)-ARYL-17,17-SPIROTHIOLANE-SUBSTITUTED STEROIDS |
| 04/17/2002 | EP1196419A1 Potassium channel blocking agents |
| 04/17/2002 | EP1196407A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 04/17/2002 | EP1196391A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 04/17/2002 | EP1196188A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196186A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 04/17/2002 | EP1196184A1 Compositions and methods for treatment of sexual dysfunction |
| 04/17/2002 | EP1196159A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 04/17/2002 | EP1196153A2 Process for the improvement of spermatozoa fertilization activity |
| 04/17/2002 | EP1196047A1 Prophylactic dietary supplement based on milk |
| 04/17/2002 | EP0906127B1 Novel devices for transdermal administering of trimegestone |
| 04/17/2002 | CN1345335A Melanocortin receptor ligands |
| 04/17/2002 | CN1345332A C-terminal modified (N-substituted)-2 indolylcarbonyldiptides as inhibitors of ICE/CED-3 family of cysteine proteases |
| 04/17/2002 | CN1345320A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 04/17/2002 | CN1345319A Triazole compounds with dopamine-D3-receptor affinity |
| 04/17/2002 | CN1345318A Triazole compounds with dopamine -D3-receptor affinity |
| 04/17/2002 | CN1345315A Hydroxymatatairesinol in cancer prevention |
| 04/17/2002 | CN1344744A Human testicular development specific protein-27 gene encoding protein |
| 04/17/2002 | CN1344743A Human testicular development specific protein-26 gene encoding protein |
| 04/17/2002 | CN1344742A Human testicualr development specific protein-24 gene encoding protein |
| 04/17/2002 | CN1344741A Human testicular development specific protein-21 gene encoding protein |
| 04/17/2002 | CN1344740A Human testicular development specific protein-20 gene encoding protein |
| 04/17/2002 | CN1344739A Human testicular development specific protein-20B gene encoding protein |
| 04/17/2002 | CN1344738A Human testicular development specific protein-18 gene encoding protein |
| 04/17/2002 | CN1344737A Human testicular development specific protein-5 gene encoding protein |
| 04/17/2002 | CN1344736A 9-0-acetyl esterase gene encoding protein |
| 04/17/2002 | CN1344735A Human testicular development specific protein-19 gene encoding protein |
| 04/17/2002 | CN1344555A Pure Chinese medicine prepn for treating erection mulfunction |
| 04/17/2002 | CN1082961C Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal and applications as medicine and pharmaceutical compositions thereof |
| 04/16/2002 | US6372926 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof |
| 04/16/2002 | US6372788 Method for supplying bioavailable methionine to a cow |
| 04/16/2002 | US6372776 Crystalline(−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate |
| 04/16/2002 | US6372757 Phenylurea and phenylthio urea derivatives |
| 04/16/2002 | US6372743 Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines |
| 04/16/2002 | US6372733 Hexahydro-5-imino-1,4-1,4-thiazepine derivatives as inhibitors of nitric oxide synthases |
| 04/16/2002 | US6372711 Receptor binding assay using polypeptide have contiguous sequence of extracellular domain or polypeptide mutein genetically engineered by insertion, deletion, or replacement |
| 04/16/2002 | US6372494 Culturing fibroblast cells in three-dimensions in a cell culture medium; removing conditioned medium from the cultured cells; combining conditioned medium with a pharmaceutically acceptable carrier |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372454 Also vectors, host cells; screening methods for identifying agonists or antagonists of follistatin-3 activity; diagnostic methods for detecting reproductive system and cell differentiation disorders and treating these |
| 04/16/2002 | US6372266 Medicinal composition for treating dysmenorrhea and endometriosis industrial use |
| 04/16/2002 | US6372209 Vaginal lactobacillus medicant |
| 04/16/2002 | CA2061665C Treatment of lower urinary tract disorders |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
| 04/11/2002 | WO2002028865A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028859A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028858A2 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 04/11/2002 | WO2002028831A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | WO2002028817A1 Substituted 1-aminobutan-3-ol derivatives |
| 04/11/2002 | WO2002028433A2 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 04/11/2002 | WO2002028418A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/11/2002 | WO2002028405A2 Method for inducing onset of the reproductive cycle of female breeding animals |
| 04/11/2002 | WO2002028396A1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 04/11/2002 | WO2002028347A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/11/2002 | WO2001092581A8 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |